Filing Details

Accession Number:
0001181431-12-001795
Form Type:
5
Zero Holdings:
No
Publication Time:
2012-01-06 18:20:29
Reporting Period:
2011-12-31
Filing Date:
2012-01-06
Accepted Time:
2012-01-06 18:20:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
850261 Sorrento Therapeutics Inc. SRNE Services-Commercial Physical & Biological Research (8731) 330344842
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008155 R Donald Scifres 80 Rose Orchard Way
San Jose CA 95134
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-12-29 12,500,000 $0.16 48,658,594 No 4 P Indirect see footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect see footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 36,158,594 Indirect see footnote
Footnotes
  1. In December 2010, The Donald R. Scifres 2010 Annuity Trust V purchased 25,000,000 shares of common stock for an aggregate price of $3,500,000. This transaction should have previously been reported on Form 3.
  2. All shares are owned by two family trusts both of which the Reporting Person is Trustee and SDL Ventures, LLC in which the Reporting Person has a controlling interest.
  3. In December 2011, The Donald R. Scifres 2011 Annuity Trust Y purchased 12,500,000 shares of common stock for an aggregate price of $2,000,000. This transaction should have previously been reported on Form 4.
  4. All shares are owned by three family trusts all of which the Reporting Person is Trustee and SDL Ventures, LLC in which the Reporting Person has a controlling interest.
  5. Shares beneficially owned by the Reporting Person as of 12/31/10.
  6. Shares beneficially owned by the Reporting Person as of 12/31/11.